Abstract submissions for PVRI 2025 Rio: Embracing heterogeneity are now open! The best abstracts will be considered for travel awards. All accepted abstracts will be published in our journal, Pulmonary Circulation, and may appear on our website.
The PVRI Innovative Drug Development Initiative (IDDI) Access to Care Workstream created the Access to Care poster which was presented at the PHA Conference in Indianapolis (15-18 August, 2024).
The purpose of the the Pulmonary Hypertension Association’s award is to support research aimed at addressing early diagnosis, education, and improving clinical outcomes and treatments for pulmonary hypertension (PH) patients who may be impacted by health inequities. Awards may be approved for up to a two (2) year period, up to $50,000/year.
Applications for the Pulmonary Hypertension/Pulmonary Vascular Disease (PH/PVD) Fellowship at the University of Pennsylvania for the academic year starting July 2025 are open.
Cereno Scientific, a pioneering biotech developing innovative treatments for rare and common cardiovascular diseases, has joined PVRI as a Roundtable member.
The Burke Advanced Fellowship in Pulmonary Heart Disease at The Brigham and Women’s Hospital and Harvard Medical School invites applications for an advanced fellowship in pulmonary heart disease starting 1 July 2025.
We are seeking a Marketing Officer to help grow and service the charity's international membership, increase the value of our membership offer, increase our income, and deliver our e-learning programmes.
As we mark International Women's Day, we have the privilege to honour the remarkable women who dedicate their lives to combating pulmonary hypertension (PH) and improving patient care. In this celebration, we shine a spotlight on their unwavering strength, resilience, and commitment to making a difference in the lives of those affected by this challenging condition.
Rupert Swift, a brave, bold, clever, charismatic young man who embraced life to the full, developed high altitude pulmonary oedema and 3 months later, was diagnosed with functional class 3 pulmonary hypertension.
Last year Sam, Max, and Harri completed the London Tough Mudder to raise money for the PVRI. After raising an incredible £3,742 which put them in the top three Tough Mudder fundraisers of 2023, they are back this year to compete again joined by Toby and Harrison.